Nephrotoxicity pp 189-192 | Cite as

Uptake and Subcellular Distribution of Poly-L-Aspartic Acid, a Protectant Against Aminoglycoside-Induced Nephrotoxicity, in Rat Kidney Cortex

  • Paul M. Tulkens
  • Zoltan Kallay

Abstract

Williams & Hottendorf (1985), and Williams et al. (1986) have observed that the co-administration of poly-L-aspartic acid protects rats against gentamicin or amikacin-induced nephrotoxicity. Yet, they found that coadministration of polyaspartic acid increased the total amount of aminoglycoside accumulated by kidney cortex, although less drug was recovered in fractions enriched in brush-border and basolateral membranes. We showed that polyaspartic acid significantly protects against gentamicin-induced lysosomal phospholipidosis (Beauchamp et al., 1986), an early renal alteration which we previously demonstrated to be a specific and predictive index of aminoglycoside nephrotoxicity related to the accumulation of the these drugs in lysosomes (see Tulkens et al., 1985, and Tulkens, 1986, for review). Beauchamp et al. (1986), and more recently Gilbert et al. (1987) also confirmed that polyaspartic acid did not decrease, but rather increased the amount of gentamicin stored by kidney cortex. The latter results are in contradiction with the original hypothesis of Williams & Hottendorf (1985) who selected polyaspartic acid as a potential competitor for gentamicin uptake by kidney, based on the observation that it interferes with gentamicin binding to renal membrane vesicles in vitro.

Keywords

Basolateral Membrane Kidney Cortex Predictive Index Polyaspartic Acid Isopycnic Centrifugation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aubert-Tulkens, G., F. Van Hoof & P. Tulkens. 1979. Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts. Lab. Invest. 40:481–493.PubMedGoogle Scholar
  2. Beauchamp, D., G. Laurent, P. Maldague, P.M. Tulkens. 1986. Reduction of gentamicin nephrotoxicity by the concomitant administration of poly-L-aspartic acid and and poly-L-asparagine in rats. Arch. Toxicol. Supp1.9:306–309.CrossRefGoogle Scholar
  3. Carlier, M.B., G. Laurent, P.J. Claes, H.J. Vanderhaeghe, P.M. Tulkens. 1983. Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: comparative studies in vitro. Antimicrob. Agents Chemother. 23:440–449.PubMedCrossRefGoogle Scholar
  4. Giuliano, R.A., G.J. Paulus, R.A. Verpooten, V. Pattyn, D.E. Pollet, P.M. Tulkens & M.E. De Broe. 1984. Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Kidney Int. 26:838–847.PubMedCrossRefGoogle Scholar
  5. Giurgea-Marion, L., S. Toubeau, G. Laurent, J. Heuson-Stiennon & P.M. Tulkens. 1986. Impairment of lysosome-pinocytic vesicle fusion in rat kidney proximal tubules after treatment with gentamicin at low doses. Toxicol. Appl. Pharm. 86:271–285.CrossRefGoogle Scholar
  6. Laurent, G., M.B. Carlier, B. Rollman, F. Van Hoof, P. Tulkens. 1982. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem. Pharmacol. 31:3861–3870.PubMedCrossRefGoogle Scholar
  7. Tulkens, P.M., J.M. Ruysschaert, R. Brasseur, M.B, Carlier, J.P. Claes, G. Laurent & H.J. Vanderhaeghe. 1985. Computer models and structureactivity data for the prediction of aminoglycoside-induced nephrotoxicity. In: Renal Heterogeneity and Target Cell Toxicity. P.H. Bach and E.A. Lock, edit., J. Wiley & Sons, Chichester. 303–313.Google Scholar
  8. Tulkens, P.M. 1986. Experimental studies on nephrotoxicity of aminoglycosides at low doses: mechanisms and perspectives. Am. J. Med. 80:105–114.PubMedCrossRefGoogle Scholar
  9. Williams, P.D. & G.H. Hottendorf. 1985, Inhibition of renal membrane binding and nephrotoxicity of gentamicin by polyasparagine and polyaspartic acid in the rat. Res. Comm. Chem. Pathol. Pharmacol. 47:317– 320.Google Scholar
  10. Williams, P.D., G.H. Hottendorf & D.B. Bennett. 1986. Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides. J. Pharmacol. Exp. Ther. 237:919–925.Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Paul M. Tulkens
    • 1
  • Zoltan Kallay
    • 2
  1. 1.Laboratoire de Chimie Physiologique and International Institute of Cellular and Molecular PathologyUniversite Catholique de LouvainBruxellesBelgium
  2. 2.Institute of Experimental PharmacologySlovak Academy of SciencesBratislavaCzechoslovakia

Personalised recommendations